{"id":8560,"date":"2025-10-29T10:22:42","date_gmt":"2025-10-29T09:22:42","guid":{"rendered":"https:\/\/www.isrec.ch\/?p=8560"},"modified":"2025-10-29T10:25:41","modified_gmt":"2025-10-29T09:25:41","slug":"wir-gratulieren-prof-denis-migliorini","status":"publish","type":"post","link":"https:\/\/www.isrec.ch\/de\/wir-gratulieren-prof-denis-migliorini\/","title":{"rendered":"Wir gratulieren Prof. Denis Migliorini"},"content":{"rendered":"
\n\t\n\n
\n\t\t\t\n\n

Wir gratulieren Prof. Denis Migliorini, M.D., ganz herzlich zu seiner Ver\u00f6ffentlichung in der Zeitschrift \u00abNature Biomedical Engineering\u00bb. Darin werden neue therapeutische Optionen im Kampf gegen Hirntumoren beschrieben. Die ISREC Stiftung ist stolz darauf, Prof. Migliorinis Lehrstuhl f\u00fcr Hirntumorimmunologie und seine Forschung, die vielen Patienten Hoffnung spendet, unterst\u00fctzen zu k\u00f6nnen.<\/p>\n\n\n\n

Hier finden Sie zus\u00e4tzliche Informationen (auf Englisch): Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence | Nature Biomedical Engineering<\/a><\/p>\n\n\t<\/div>\n\n\n\n

\n\t\t\t\n\n
\"\"
Photo portrait<\/figcaption><\/figure>\n\n\t<\/div>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"featured_media":8561,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[51],"tags":[],"class_list":["post-8560","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nachrichten"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t